Obesity has always been a hot-button topic, surrounded by debates, finger-pointing, and confusion. A new report from a group of global...

Recently, the buzz around GLP-1 agonists, especially semaglutide (e.g. Ozempic, Wegovy), has been hard to ignore. Promoted as a...